Compare Stocks

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABIO ARCA biopharma	$3.36 +3.4%	$2.04	$1.56 ▼ $3.88	$48.72M	1.17	1.17 million shs	336,258 shs
ACHV Achieve Life Sciences	$4.55 -0.4%	$4.42	$3.03 ▼ $10.30	$155.84M	1.32	87,881 shs	10,117 shs
AKER Akers Biosciences	$2.52 +12.0%	$3.56	$1.65 ▼ $6.97	$41.96M	0.3	769,876 shs	54,002 shs
GNWSF StageZero Life Sciences	$0.04	$0.03	$0.00 ▼ $1.27	$2.46M	0.28	26,719 shs	N/A
RIOT Riot Platforms	$8.95 +8.0%	$12.54	$7.80 ▼ $20.65	$2.27B	4.25	25.41 million shs	11.41 million shs

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABIO ARCA biopharma	+1.25%	0.00%	+86.78%	+103.13%	+64.14%
ACHV Achieve Life Sciences	0.00%	+4.10%	+0.22%	+1.11%	-34.81%
AKER Akers Biosciences	+12.00%	+0.80%	-12.50%	+1,247.54%	+57.49%
GNWSF StageZero Life Sciences	+35.42%	+35.42%	+44.44%	+35.89%	-34.87%
RIOT Riot Platforms	+4.02%	-14.97%	-25.25%	-19.44%	-31.54%

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABIO ARCA biopharma	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ACHV Achieve Life Sciences	1.5011 of 5 stars	3.5	2.0	0.0	0.0	3.0	0.0	0.6
AKER Akers Biosciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GNWSF StageZero Life Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RIOT Riot Platforms	3.4924 of 5 stars	4.5	4.0	0.0	0.0	1.5	1.7	1.3

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABIO ARCA biopharma	N/A	N/A	N/A	N/A
ACHV Achieve Life Sciences	3.00	Buy	$17.25	279.12% Upside
AKER Akers Biosciences	N/A	N/A	N/A	N/A
GNWSF StageZero Life Sciences	N/A	N/A	N/A	N/A
RIOT Riot Platforms	3.00	Buy	$18.96	111.88% Upside

Current Analyst Ratings

Latest ACHV, GNWSF, ABIO, AKER, and RIOT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/17/2024	ACHV Achieve Life Sciences	Jonestrading Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$20.00
4/10/2024	RIOT Riot Platforms	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$15.00 ➝ $15.50
4/5/2024	RIOT Riot Platforms	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$17.00 ➝ $16.00
4/1/2024	ACHV Achieve Life Sciences	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$18.00
4/1/2024	RIOT Riot Platforms	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$20.00
3/28/2024	RIOT Riot Platforms	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$20.00
3/20/2024	RIOT Riot Platforms	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$15.00
3/18/2024	RIOT Riot Platforms	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$18.00
3/5/2024	ACHV Achieve Life Sciences	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$19.00 ➝ $11.00
3/4/2024	RIOT Riot Platforms	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$20.00
2/28/2024	RIOT Riot Platforms	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$19.00 ➝ $20.00

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABIO ARCA biopharma	N/A	N/A	N/A	N/A	$2.89 per share	N/A
ACHV Achieve Life Sciences	N/A	N/A	N/A	N/A	($0.07) per share	N/A
AKER Akers Biosciences	$1.58M	26.56	N/A	N/A	$5.38 per share	0.47
GNWSF StageZero Life Sciences	$4.15M	0.59	N/A	N/A	($0.02) per share	-1.95
RIOT Riot Platforms	$280.70M	8.08	$1.10 per share	8.12	$9.14 per share	0.98

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABIO ARCA biopharma	-$5.34M	-$0.37	N/A	∞	N/A	N/A	-13.80%	-13.33%	4/22/2024 (Estimated)
ACHV Achieve Life Sciences	-$29.82M	-$1.53	N/A	N/A	N/A	N/A	-936.70%	-127.66%	5/14/2024 (Estimated)
AKER Akers Biosciences	-$3.89M	N/A	0.00	∞	N/A	N/A	-87.42%	-73.31%	N/A
GNWSF StageZero Life Sciences	-$6.86M	-$0.28	N/A	∞	N/A	-200.26%	N/A	-165.13%	N/A
RIOT Riot Platforms	-$49.47M	-$0.27	N/A	38.91	N/A	-17.62%	0.89%	0.81%	5/8/2024 (Estimated)

Latest ACHV, GNWSF, ABIO, AKER, and RIOT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/22/2024	Q4 2023	RIOT Riot Platforms	-$0.29	$0.48	+$0.77	$0.48	$84.94 million	$78.83 million
2/1/2024	Q4 2023	ABIO ARCA biopharma	N/A	-$0.08	-$0.08	-$0.08	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABIO ARCA biopharma	N/A	N/A	N/A	N/A	N/A
ACHV Achieve Life Sciences	N/A	N/A	N/A	N/A	N/A
AKER Akers Biosciences	N/A	N/A	N/A	N/A	N/A
GNWSF StageZero Life Sciences	N/A	N/A	N/A	N/A	N/A
RIOT Riot Platforms	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABIO ARCA biopharma	N/A	59.01	59.01
ACHV Achieve Life Sciences	4.02	0.82	0.82
AKER Akers Biosciences	N/A	9.22	9.22
GNWSF StageZero Life Sciences	N/A	1.15	1.08
RIOT Riot Platforms	N/A	8.33	8.33

Ownership

Institutional Ownership

Company	Institutional Ownership
ABIO ARCA biopharma	56.44%
ACHV Achieve Life Sciences	33.52%
AKER Akers Biosciences	5.52%
GNWSF StageZero Life Sciences	0.02%
RIOT Riot Platforms	40.27%

Insider Ownership

Company	Insider Ownership
ABIO ARCA biopharma	30.90%
ACHV Achieve Life Sciences	2.00%
AKER Akers Biosciences	0.29%
GNWSF StageZero Life Sciences	N/A
RIOT Riot Platforms	4.40%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ABIO ARCA biopharma	4	14.50 million	10.02 million	Optionable
ACHV Achieve Life Sciences	20	34.25 million	33.57 million	Optionable
AKER Akers Biosciences	4	16.65 million	N/A	Not Optionable
GNWSF StageZero Life Sciences	51	63.00 million	N/A	Not Optionable
RIOT Riot Platforms	534	253.54 million	242.38 million	Optionable

ACHV, GNWSF, ABIO, AKER, and RIOT Headlines

Source	Headline
	Bitcoin halving could set up cryptocurrency for long-term gains finance.yahoo.com - April 18 at 6:14 PM
	Riot Energizes New Corsicana Facility in Navarro County, Texas finance.yahoo.com - April 18 at 1:14 PM
	Down 58% From Its High, Could Riot Platforms Stock Get Help From the Bitcoin Halving? fool.com - April 18 at 4:54 AM
	Australia news live: Greens warn of ‘massive indexation hit’ to Hecs/Help debt in June; first person charged in investigation into Wakeley riot theguardian.com - April 18 at 1:31 AM
	Australia news live: man to appear in court over Sydney riot; Daniel Andrews banned from Russia theguardian.com - April 17 at 8:31 PM
	Ex-'Real Housewives' star posted photos of son on Jan. 6 that led to riot charges yahoo.com - April 17 at 8:31 PM
	Riot Platforms, Inc. (RIOT) Declines More Than Market: Some Information for Investors zacks.com - April 17 at 6:56 PM
	Bitcoin Halving Playbook: 3 Mining Stocks to Buy for Crypto Profits investorplace.com - April 17 at 12:50 PM
	Sydney church stabbing a ‘terrorist’ attack say police as teen suspect detained after public riot msn.com - April 17 at 10:30 AM
	Hong Kong student jailed for laundering HK$600,000 from fundraising platform used to help arrested protesters msn.com - April 17 at 10:30 AM
	Sydney church stabbing a ‘terrorist’ attack say police as teen suspect detained after public riot - live msn.com - April 17 at 10:30 AM
	Bernstein Is Pounding the Table on Riot Platforms (RIOT) Stock msn.com - April 17 at 10:30 AM
	Bernstein Is Pounding the Table on Riot Platforms (RIOT) Stock investorplace.com - April 17 at 10:22 AM
	Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving (RIOT) marketbeat.com - April 17 at 7:10 AM
	Behind the Scenes of Riot Platforms's Latest Options Trends benzinga.com - April 16 at 6:50 PM
	Bitcoin halving, crypto mining: Riot Platforms CEO discusses finance.yahoo.com - April 15 at 9:03 PM
	Global girl group XG collaborates with Riot Games for exclusive track “Undefeated” hallyusg.net - April 14 at 8:25 AM
	Introducing Anarkitty ($RIOT): The Revolutionary Meme Coin Set to Transform Finance techbullion.com - April 13 at 12:04 PM
	Riot Platforms, Inc. (RIOT) Is a Trending Stock: Facts to Know Before Betting on It zacks.com - April 12 at 10:05 AM
	Beyond The Numbers: 14 Analysts Discuss Riot Platforms Stock markets.businessinsider.com - April 10 at 7:07 PM
	Riot Platforms, Inc. (RIOT) Suffers a Larger Drop Than the General Market: Key Insights zacks.com - April 10 at 6:56 PM
	EXCLUSIVE: Marathon, Riot, Hut8 CEOs Tell Benzinga How Bitcoin Halving Will Impact Miners msn.com - April 9 at 7:51 PM
	Election Year Encore: Can 2020's Top 7 Stock Winners Repeat Their Performance in 2024? investorplace.com - April 9 at 4:30 PM
	How much will RIOT stock be worth if Bitcoin hits $100,000? finbold.com - April 9 at 6:48 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Foot Locker Builds Up Another Head of Steam; Gains Imminent
March 28, 2024 10:58 AM
View Foot Locker Builds Up Another Head of Steam; Gains Imminent
5 Stocks in the Current Bull Market with Upside to Come
April 5, 2024 10:14 AM
View 5 Stocks in the Current Bull Market with Upside to Come
5 Top-Rated Dividend Stocks With Double-Digit Upside
March 25, 2024 11:19 AM
View 5 Top-Rated Dividend Stocks With Double-Digit Upside
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
April 12, 2024 9:00 AM
View JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show

All Headlines

Company Descriptions

ARCA biopharma

NASDAQ:ABIO

ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.

Achieve Life Sciences

NASDAQ:ACHV

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Akers Biosciences

NASDAQ:AKER

Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was incorporated in 1989 and is headquartered in New York, New York.

StageZero Life Sciences

OTCMKTS:GNWSF

StageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. It also offers Aristotle, a multi-cancer panel test for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer; and COVID PCR testing and blood test analysis. StageZero Life Sciences Ltd. is headquartered in Richmond Hill, Canada.

Riot Platforms

NASDAQ:RIOT

Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. The company operates through three segments: Bitcoin Mining, Data Center Hosting, and Engineering. It also provides co-location services for institutional-scale bitcoin mining companies; critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners; operation of data centers; and maintenance/management of computing capacity. In addition, the company engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; and electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial, and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial